Bosniak 2019版II类和IIF类T1高信号囊性肾肿块的恶性风险
该回顾性单中心研究纳入72个Bosniak 2019版II类或IIF类、无强化、T1高信号的囊性肾肿块,由3名阅片者独立将每个肿块归入6种预定义的T1高信号模式之一,旨在确定各模式的恶性比例。结果显示5/72(7%)为恶性,模式A、B、D无恶性,模式F恶性比例可达25%(5/20),恶性肿块更可能被归为模式E或F(p=0.003–0.039),阅片者间一致性为Gwet AC 0.68。
要点
- Bosniak 2019版IIF类无强化、T1高信号且含液-液平面的囊性肾肿块可能为良性。
- 无强化、不均匀T1高信号且无明确模式的囊性肾肿块恶性比例可达25%(5/20)。
- 恶性肿块更可能被归为模式E或F(p=0.003–0.039),阅片者间一致性为Gwet AC 0.68。
核心结论
- Bosniak 2019版IIF类无强化且含液-液平面的不均匀T1高信号囊性肾肿块可能为良性;无强化、不均匀T1高信号且无明确模式的肿块恶性比例可达25%(5/20)。
研究设计与样本
- 回顾性单中心研究,纳入72个Bosniak 2019版II类或IIF类、无强化、T1高信号的囊性肾肿块,由3名阅片者独立将每个肿块归入6种预定义的T1高信号模式之一,诊断经组织病理学或随访影像证实(5年大小和形态稳定、缩小≥30%、消退或Bosniak降级)。
关键影像表现/征象
- 预定义6种T1高信号模式:均匀(模式A)、液-液平面(模式B)、周边显著T1高信号(模式C)、含T1高信号无强化结节(模式D)、周边T1低信号(模式E)、不均匀T1高信号且无明确模式(模式F)。
- 72个肿块中,平均归入模式A 11个(15%)、模式B 21个(29%)、模式C 6个(8%)、模式D 7个(10%)、模式E 5个(7%)、模式F 22个(31%)。
- 5/72(7%)为恶性,模式A、B、D均无恶性。
- 模式C的平均恶性比例为5%(0/9、1/6、0/4),模式E为13%(0/4、1/3、1/7),模式F为18%(5/20、3/21、4/25)。
- 恶性肿块更可能被归为模式E或F(p=0.003–0.039)。
诊断标准与关键数值
- 诊断经组织病理学或随访影像证实:5年大小和形态稳定、缩小≥30%、消退或Bosniak降级。
- 模式F的恶性比例可达25%(5/20)。
- 阅片者间一致性为Gwet AC 0.68(一致性程度为substantial)。
临床应用与阅片要点
- 对Bosniak 2019版II类或IIF类、无强化、T1高信号的囊性肾肿块,可评估其T1高信号模式辅助判断恶性风险。
- 无强化、不均匀T1高信号且含液-液平面的肿块可能为良性;无明确模式的不均匀T1高信号肿块恶性比例可达25%(5/20)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Bosniak classification version 2019 includes cystic masses in class II and IIF based partly on their hyperintense appearance at T1-weighted MRI. The prevalence of malignancy in non-enhancing heterogeneously T1-hyperintense masses is unknown, nor whether the pattern of T1 hyperintensity affects malignancy likelihood.
PURPOSE: To determine the malignancy proportion among six patterns of T1 hyperintensity within non-enhancing cystic renal masses.
METHODS: This retrospective, single-institution study included 72 Bosniak class II and IIF, non-enhancing, T1-hyperintense cystic renal masses. Diagnosis was confirmed by histopathology or by follow-up imaging demonstrating 5-year size and morphologic stability, decreased in size by ≥ 30%, resolution, or Bosniak down-classification. Six patterns of T1 hyperintensity were pre-defined: homogeneous (pattern A), fluid-fluid level (pattern B), peripherally markedly T1-hyperintense (pattern C), containing a T1-hyperintense non-enhancing nodule (pattern D), peripherally T1-hypointense (pattern E), and heterogeneously T1-hyperintense without a distinct pattern (pattern F). Three readers independently assigned each mass to a pattern. Individual and mean malignancy proportion were determined. Mann-Whitney test and Fischer's exact test compared the likelihood of malignancy between patterns. Inter-reader agreement was analyzed with Gwet's agreement coefficient (AC).
RESULTS: Among 72 masses, the mean number of masses assigned was 11 (15%) to pattern A, 21 (29%) to pattern B, 6 (8%) to pattern C, 7 (10%) to pattern D, 5 (7%) to pattern E, and 22 (31%) to pattern F. Five of 72 masses (7%) were malignant; none was assigned pattern A, B, or D. Mean malignancy proportion was 5% (0/9, 1/6, and 0/4) for pattern C, 13% (0/4, 1/3, and 1/7) for pattern E, and 18% (5/20, 3/21, and 4/25) for pattern F. Malignant masses were more likely assigned to pattern E or F (p = 0.003-0.039). Inter-reader agreement was substantial (Gwet's AC: 0.68).
CONCLUSION: Bosniak version 2019 class IIF masses that are non-enhancing and heterogeneously T1-hyperintense with a fluid-fluid level are likely benign. Those that are non-enhancing and heterogeneously T1-hyperintense without a distinct pattern have a malignancy proportion up to 25% (5/20).
引用
- Shen, Tse, Lemieux, et al. Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses. Abdom Radiol (NY). 2023. PMID: 37202641. doi:10.1007/s00261-023-03955-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。